Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pivotal Bioventure Partners China is a venture capital firm established in 2017, specializing in strategic investments within the life sciences industry. The firm is headquartered in Shanghai, China, and operates as a member of Nan Fung Life Sciences. Pivotal Bioventure China focuses on partnering with innovative healthcare companies, particularly in the Greater China region, to address significant unmet medical needs.
Since its inception, the firm has aimed to drive innovation within the life sciences ecosystem, emphasizing transformative therapeutic-focused healthcare solutions. The firm’s commitment to advancing healthcare aligns with the growing demand for innovative medical solutions in one of the world's largest markets.
Pivotal Bioventure China concentrates its investments in the life sciences sector, specifically targeting transformative therapeutic-focused healthcare companies. The firm seeks opportunities that can drive innovation and address critical healthcare challenges in the Greater China region. This focus allows Pivotal Bioventure to align its investment strategy with the evolving needs of the healthcare market.
The firm is particularly interested in companies that demonstrate potential for significant advancements in therapeutic solutions. By investing in these innovative healthcare companies, Pivotal Bioventure aims to contribute to the development of groundbreaking medical technologies and treatments.
What are Pivotal Bioventure China's investment criteria?
Pivotal Bioventure China invests in transformative therapeutic-focused healthcare companies within the life sciences sector. The firm looks for innovative solutions that address unmet medical needs in the Greater China region.
How can founders pitch to Pivotal Bioventure China?
Founders interested in pitching to Pivotal Bioventure China should prepare a detailed presentation that outlines their business model, market potential, and innovative aspects of their healthcare solutions. A clear articulation of how their company addresses significant healthcare challenges is essential.
What makes Pivotal Bioventure China different from other investors?
Pivotal Bioventure China differentiates itself through its exclusive focus on the life sciences sector and its strategic partnerships with innovative healthcare companies. The firm’s affiliation with Nan Fung Life Sciences enhances its capabilities in driving healthcare advancements.
What is the geographic scope of Pivotal Bioventure China's investments?
The firm primarily focuses on the Greater China region, targeting opportunities that can significantly impact the local healthcare landscape.
What is the firm's approach to post-investment involvement?
Pivotal Bioventure China actively engages with its portfolio companies to support their growth and innovation efforts. The firm aims to provide resources and strategic guidance to help these companies succeed in the competitive healthcare market.
What is the typical check size for investments made by Pivotal Bioventure China?
Specific check sizes are not disclosed, but the firm focuses on strategic investments that align with its mission to drive innovation in the life sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.